Showing results (411-420 of 833) with videos related to
Sort By:
Pageof 84
Cardiovascular Diabetology|August 24, 2023
Effect of semaglutide on major adverse cardiovascular events by baseline kidney parameters in participants with type 2 diabetes and at high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc pooled analysisPeter Rossing, Stephen C Bain, Heidrun Bosch-Traberg, et al.Diabetologia|November 4, 2015
Cardiac (82)Rb PET/CT for fast and non-invasive assessment of microvascular function and structure in asymptomatic patients with type 2 diabetesBernt J von Scholten, Philip Hasbak, Thomas E Christensen, et al.Scientific Reports|November 10, 2019
Lipidomic analysis reveals sphingomyelin and phosphatidylcholine species associated with renal impairment and all-cause mortality in type 1 diabetesNete Tofte, Tommi Suvitaival, Linda Ahonen, et al.Diabetes, Obesity & Metabolism|December 27, 2016
The effects of atrasentan on urinary metabolites in patients with type 2 diabetes and nephropathyMichelle J Pena, Dick de Zeeuw, Dennis Andress, et al.Journal of Hypertension|March 14, 2007
Renal function and risk for cardiovascular events in type 2 diabetic patients with hypertension: the RENAAL and LIFE studiesWouter B A Eijkelkamp, Zhongxin Zhang, Barry M Brenner, et al.American Heart Journal|October 11, 2011
Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: an analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT)John J V McMurray, Hajime Uno, Petr Jarolim, et al.Stem Cell Research & Therapy|June 28, 2022
Novel topical allogeneic bone-marrow-derived mesenchymal stem cell treatment of hard-to-heal diabetic foot ulcers: a proof of concept studyJonas Askø Andersen, Anne Rasmussen, Marie Frimodt-Møller, et al.Nephrology (Carlton, Vic.)|July 15, 2021
Sodium-glucose cotransporter 2 inhibitors for diabetes mellitus control after kidney transplantation: Review of the current evidenceMehmet Kanbay, Atalay Demiray, Baris Afsar, et al.Journal of Diabetes and Its Complications|October 26, 2018
Left ventricular remodelling and cardiac chamber sizes in long-term, normoalbuminuric type 1 diabetes patients with and without cardiovascular autonomic neuropathyHenrik Ø Hjortkjær, Tonny Jensen, Jannik Hilsted, et al.American Journal of Nephrology|October 30, 2023
Methods Article for a Study Protocol: Study Design and Baseline Characteristics for Aldosterone Synthase Inhibition in Chronic Kidney DiseaseKatherine R Tuttle, Peter Rossing, Sibylle J Hauske, et al.Pageof 84